Close
  Indian J Med Microbiol
 

Figure 3: Drug-associated symptoms varied with the inhalation time of hydrogen (H2). Note: (A) Immunotherapy-H2 group (n = 10). (B) Target-H2 therapy group (n = 18). (C) Chemotherapy-H2 therapy group (n =10). Drug-associated adverse event was compared using linear regression analysis.

Figure 3: Drug-associated symptoms varied with the inhalation time of hydrogen (H<sub>2</sub>).
Note: (A) Immunotherapy-H<sub>2</sub> group (<i>n</i> = 10). (B) Target-H<sub>2</sub> therapy group (<i>n</i> = 18). (C) Chemotherapy-H<sub>2</sub> therapy group (<i>n</i> =10). Drug-associated adverse event was compared using linear regression analysis.